US 9701758
Anti-CD19 scFv (FMC63) polypeptide
granted A61KA61K40/11A61K40/31
Quick answer
US patent 9701758 (Anti-CD19 scFv (FMC63) polypeptide) held by The Board of Regents of the University of Texas System expires Mon Jul 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Jul 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K40/11, A61K40/31, A61K40/4211, A61K40/428